Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform

Oversubscribed round co-led by Cormorant Asset Management and Fairmount Funds, supported by a strong syndicate of new and existing investors PHILADELPHIA, May 18, 2021 -- (Healthcare Sales & Marketing Network) -- Interius BioTherapeutics, a preclinical... Biopharmaceuticals, Venture Capital Interius BioTherapeutics, gene therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news